Literature DB >> 24771859

Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice.

Yukiko Komeno1, Ming Yan1, Shinobu Matsuura1, Kentson Lam2, Miao-Chia Lo1, Yi-Jou Huang3, Daniel G Tenen4, James R Downing5, Dong-Er Zhang6.   

Abstract

RUNX1 is an important transcription factor for hematopoiesis. There are multiple alternatively spliced isoforms of RUNX1. The best known isoforms are RUNX1a from use of exon 7A and RUNX1b and c from use of exon 7B. RUNX1a has unique functions due to its lack of C-terminal regions common to RUNX1b and c. Here, we report that the ortholog of human RUNX1a was only found in primates. Furthermore, we characterized 3 Runx1 isoforms generated by exon 6 alternative splicing. Runx1bEx6(-) (Runx1b without exon 6) and a unique mouse Runx1bEx6e showed higher colony-forming activity than the full-length Runx1b (Runx1bEx6(+)). They also facilitated the transactivation of Runx1bEx6(+). To gain insight into in vivo functions, we analyzed a knock-in (KI) mouse model that lacks isoforms Runx1b/cEx6(-) and Runx1bEx6e. KI mice had significantly fewer lineage-Sca1(+)c-Kit(+) cells, short-term hematopoietic stem cells (HSCs) and multipotent progenitors than controls. In vivo competitive repopulation assays demonstrated a sevenfold difference of functional HSCs between wild-type and KI mice. Together, our results show that Runx1 isoforms involving exon 6 support high self-renewal capacity in vitro, and their loss results in reduction of the HSC pool in vivo, which underscore the importance of fine-tuning RNA splicing in hematopoiesis.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771859      PMCID: PMC4055923          DOI: 10.1182/blood-2013-08-521252

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.

Authors:  Hui Huang; Andrew J Woo; Zachary Waldon; Yocheved Schindler; Tyler B Moran; Helen H Zhu; Gen-Sheng Feng; Hanno Steen; Alan B Cantor
Journal:  Genes Dev       Date:  2012-07-03       Impact factor: 11.361

2.  RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Authors:  Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

3.  Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Authors:  Hideki Makishima; Valeria Visconte; Hirotoshi Sakaguchi; Anna M Jankowska; Sarah Abu Kar; Andres Jerez; Bartlomiej Przychodzen; Manoj Bupathi; Kathryn Guinta; Manuel G Afable; Mikkael A Sekeres; Richard A Padgett; Ramon V Tiu; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-02-09       Impact factor: 22.113

4.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

Review 5.  New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Authors:  Cornelia Johanna Franziska Scheitz; Tudorita Tumbar
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

6.  Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia.

Authors:  Oreth Montero-Ruíz; Miguel Angel Alcántara-Ortigoza; Miguel Betancourt; Rocío Juárez-Velázquez; Humberto González-Márquez; Patricia Pérez-Vera
Journal:  Leuk Res       Date:  2012-06-29       Impact factor: 3.156

7.  Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.

Authors:  Shinobu Matsuura; Yukiko Komeno; Kristen E Stevenson; Joseph R Biggs; Kentson Lam; Tingdong Tang; Miao-Chia Lo; Xiuli Cong; Ming Yan; Donna S Neuberg; Dong-Er Zhang
Journal:  Blood       Date:  2012-08-23       Impact factor: 22.113

Review 8.  RUNX family: Regulation and diversification of roles through interacting proteins.

Authors:  Linda Shyue Huey Chuang; Kosei Ito; Yoshiaki Ito
Journal:  Int J Cancer       Date:  2012-12-19       Impact factor: 7.396

9.  Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation.

Authors:  Wenguang Cao; Aleh Razanau; Dairong Feng; Vincent G Lobo; Jiuyong Xie
Journal:  Nucleic Acids Res       Date:  2012-06-08       Impact factor: 16.971

10.  Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation.

Authors:  Gareth Brady; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  Nucleic Acids Res       Date:  2012-12-18       Impact factor: 16.971

View more
  23 in total

Review 1.  Differential evolution of signal-responsive RNA elements and upstream factors that control alternative splicing.

Authors:  Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

Review 2.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.

Authors:  Louis R Ghanem; Andrew Kromer; Ian M Silverman; Xinjun Ji; Matthew Gazzara; Nhu Nguyen; Gabrielle Aguilar; Massimo Martinelli; Yoseph Barash; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

4.  Role of alternative splicing in hematopoietic stem cells during development.

Authors:  Yimeng Gao; Radovan Vasic; Stephanie Halene
Journal:  Stem Cell Investig       Date:  2018-08-23

5.  Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms.

Authors:  Hiroko Sakurai; Yuka Harada; Yosuke Ogata; Yuki Kagiyama; Naoki Shingai; Noriko Doki; Kazuteru Ohashi; Toshio Kitamura; Norio Komatsu; Hironori Harada
Journal:  Blood Adv       Date:  2017-07-31

6.  SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.

Authors:  Yukiko Komeno; Yi-Jou Huang; Jinsong Qiu; Leo Lin; YiJun Xu; Yu Zhou; Liang Chen; Dora D Monterroza; Hairi Li; Russell C DeKelver; Ming Yan; Xiang-Dong Fu; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2015-06-29       Impact factor: 4.272

7.  A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation.

Authors:  Amanda G Davis; Jaclyn M Einstein; Dinghai Zheng; Nathan D Jayne; Xiang-Dong Fu; Bin Tian; Gene W Yeo; Dong-Er Zhang
Journal:  Blood Adv       Date:  2021-03-09

Review 8.  Glycogen synthase kinase-3 and alternative splicing.

Authors:  Xiaolei Liu; Peter S Klein
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-08-17       Impact factor: 9.957

9.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.

Authors:  Liang Chen; Jia-Yu Chen; Yi-Jou Huang; Ying Gu; Jinsong Qiu; Hao Qian; Changwei Shao; Xuan Zhang; Jing Hu; Hairi Li; Shunmin He; Yu Zhou; Omar Abdel-Wahab; Dong-Er Zhang; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

10.  Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock.

Authors:  Mao-Cai Luo; Si-Yuan Zhou; Dan-Ying Feng; Jun Xiao; Wei-Yun Li; Chun-Di Xu; Hong-Yan Wang; Tong Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.